Cited by 49

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma

Gao, Ge, Johnson, Sarah H, Vasmatzis, George, Pauley, Christina E, Tombers, Nicole M., Kasperbauer, Jan L, Smith, David I.·2017·Genes, Chromosomes and Cancer

Abstract

Common fragile sites (CFS) are chromosome regions that are prone to form gaps or breaks in response to DNA replication stress. They are often found as hotspots for sister chromatid exchanges, deletions, and amplifications in different cancers. Many of the CFS regions are found to span genes whose genomic sequence is greater than 1 Mb, some of which have been demonstrated to function as important tumor suppressors. CFS regions are also hotspots for human papillomavirus (HPV) integrations in cervical cancer. We used mate‐pair sequencing to examine HPV integration events and chromosomal structural variations in 34 oropharyngeal squamous cell carcinoma (OPSCC). We used endpoint PCR and Sanger sequencing to validate each HPV integration event and found HPV integrations preferentially occurred within CFS regions similar to what is observed in cervical cancer. We also found that many of the chromosomal alterations detected also occurred at or near the cytogenetic location of CFSs. Several large genes were also found to be recurrent targets of rearrangements, independent of HPV integrations, including CSMD1 (2.1Mb), LRP1B (1.9Mb), and LARGE1 (0.7Mb). Sanger sequencing revealed that the nucleotide sequences near to identified junction sites contained repetitive and AT‐rich sequences that were shown to have the potential to form stem‐loop DNA secondary structures that might stall DNA replication fork progression during replication stress. This could then cause increased instability in these regions which could lead to cancer development in human cells. Our findings suggest that CFSs and some specific large genes appear to play important roles in OPSCC. © 2016 Wiley Periodicals, Inc.

Overview

Integrity signals

Registry

Crossref · 10.1002/gcc.22415

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 67

  1. 10.1101/gr.164806.113 · DOI
  2. Alazawi W, 2002, Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16, Cancer Res, 62, 6959
  3. 10.1002/jcp.21099 · DOI
  4. 10.1128/jvi.61.4.962-971.1987 · DOI
  5. Bednarek AK, 2000, WWOX, a novel WW domain‐containing protein mapping to human chromosome 16q23.3‐24.1, a region frequently affected in breast cancer, Cancer Res, 60, 2140
  6. 10.1038/nature08822 · DOI · Paper page
  7. 10.1007/s00432-008-0490-3 · DOI
  8. 10.1093/nar/gkp1245 · DOI
  9. 10.1200/JCO.2007.14.1713 · DOI
  10. 10.1093/hmg/11.23.2887 · DOI
  11. 10.1038/ejhg.2010.212 · DOI
  12. 10.1158/0008-5472.CAN-12-0203 · DOI
  13. Duensing S, 2002, The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability, Cancer Res, 62, 7075
  14. 10.1126/science.2537532 · DOI · Paper page
  15. 10.1016/0042-6822(87)90478-8 · DOI
  16. 10.1182/blood-2010-08-303305 · DOI
  17. 10.1038/sj.onc.1207006 · DOI
  18. 10.1016/j.jcv.2013.12.006 · DOI
  19. 10.1007/s00018-014-1753-6 · DOI
  20. 10.1177/1535370213519213 · DOI
  21. 10.1128/JVI.75.10.4705-4712.2001 · DOI
  22. 10.1007/BF00272988 · DOI
  23. Greenspan DL, 1997, Loss of FHIT expression in cervical carcinoma cell lines and primary tumors, Cancer Res, 57, 4692
  24. 10.1016/j.molcel.2011.10.013 · DOI
  25. Henshall SM, 2003, Survival analysis of genome‐wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse, Cancer Res, 63, 4196
  26. 10.1038/ng.3178 · DOI
  27. 10.1002/(SICI)1097-0215(19990105)80:1<25::AID-IJC6>3.0.CO;2-G · DOI
  28. 10.1002/gcc.21933 · DOI
  29. 10.1128/jvi.69.5.2989-2997.1995 · DOI
  30. 10.1038/sj.onc.1208136 · DOI
  31. 10.1038/33416 · DOI · Paper page
  32. 10.1002/ajh.23495 · DOI
  33. 10.1038/nsmb.2155 · DOI
  34. 10.1016/j.celrep.2013.07.003 · DOI
  35. 10.1016/S1040-8428(01)00129-9 · DOI
  36. Liu CX, 2000, LRP‐DIT, a putative endocytic receptor gene, is frequently inactivated in non‐small cell lung cancer cell lines, Cancer Res, 60, 1961
  37. 10.4161/cbt.8.10.8132 · DOI
  38. 10.1016/S1470-2045(10)70017-6 · DOI
  39. 10.1097/NEN.0000000000000065 · DOI
  40. 10.1016/S0092-8674(00)81034-X · DOI
  41. 10.1371/journal.pone.0088718 · DOI
  42. 10.1002/ijc.29112 · DOI
  43. 10.1016/j.molcel.2011.05.019 · DOI
  44. 10.1093/hmg/ddh155 · DOI
  45. 10.1158/0008-5472.CAN-03-3214 · DOI
  46. 10.1007/s10689-007-9160-x · DOI
  47. 10.1002/ijc.20193 · DOI
  48. 10.1002/gcc.20394 · DOI
  49. 10.1038/sj.onc.1207809 · DOI
  50. 10.1007/s00018-014-1723-z · DOI
  51. 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  52. 10.1016/0092-8674(93)90384-3 · DOI · Paper page
  53. 10.1093/jnci/88.22.1676 · DOI
  54. 10.1002/gcc.10279 · DOI
  55. 10.1016/j.canlet.2005.07.039 · DOI
  56. 10.1093/nar/gkp1131 · DOI
  57. 10.1002/ijc.20259 · DOI
  58. 10.1006/geno.1999.6020 · DOI
  59. 10.1007/s10495-012-0727-0 · DOI
  60. 10.1038/sj.onc.1206170 · DOI
  61. 10.1002/gcc.10191 · DOI
  62. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F · DOI
  63. 10.1158/0008-5472.CAN-04-0009 · DOI · Paper page
  64. 10.1101/gad.8.6.666 · DOI
  65. 10.1128/MCB.23.20.7143-7151.2003 · DOI
  66. 10.1093/nar/gkg595 · DOI · Paper page
  67. 10.1038/nrc798 · DOI

Metadata

Authors
Gao, G., Johnson, S. H., Vasmatzis, G., Pauley, C. E., Tombers, N. M., Kasperbauer, J. L., & Smith, D. I.
Affiliations
  • Division of Experimental Pathology Mayo Clinic Rochester MN
  • Biomarker Discovery Program, Center for Individualized Medicine Mayo Clinic Rochester MN
  • Division of Otolaryngology Mayo Clinic Rochester MN
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2016-11
Volume
56
Issue
1
Pages
59-74
ISSN
  • 1045-2257
  • 1098-2264
Cited by
49
References
2
Language
en
Funders
Experimental Pathology Developmental Fund from the Department of Laboratory Medicine and Pathology at Mayo Clinic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review